leadf
logo-loader
viewTodos Medical Ltd.
(
OTCQB:TOMDF
)

Todos Medical acquires Provista Diagnostics and its Videssa blood test with final payment

Todos Medical Ltd (OTCQB:TOMDF) CEO Gerald Commissiong tells Proactive it has made the final payment of $1.25 million to complete its $10 million acquisition of US-based Provista Diagnostics Inc, a medical diagnostics firm that owns the intellectual property rights to proprietary breast cancer blood test Videssa and has a diagnostic lab performing coronavirus (COVID-19) PCR testing.

Commissiong says it is currently expanding Alpharetta, Georgia-based Provista’s marketing team as it works to capitalize on its automated capabilities in COVID-19 PCR testing, variant identification, and neutralizing antibody testing.

Quick facts: Todos Medical Ltd.

Follow
OTCQB:TOMDF

Price: 0.041 USD

Market Cap: $32.52 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Todos Medical receives Amazon approval to sell immune supplements Tollovid...

Todos Medical Ltd CEO Gerald Commissiong joined Proactive's Stephen Gunnion with news that the medical diagnostics company has received approval from the Amazon e-commerce platform to sell Tollovid and Tollovid Daily, the company’s 3CL protease (MPro) inhibiting dietary supplements to support...

7 hours, 22 minutes ago

2 min read